Development and validation of an HPLC method to determine the stability of fentanyl citrate and bupivacaine hydrochloride mixtures in infusion solutions. 2012

Mikołaj Piekarski, and Anna Jelin'ska, and Kamil Szymczak
Pharmaceutical Chemistry, Karol Marcinkowski University of Medical Sciences, Poznań, Poland ; Inhospital pharmacy, Heliodor Swięcicki Clinical Hospital of PUMS, Poznań, Poland.

The use of a combination of different drugs in postoperative analgesia extends the time of analgesia, makes it more efficient and allows the use of lower drug doses, which leads to less risk of side effects and drug dependence. The aim of this study was to develop and validate an HPLC method to determine the stability of fentanyl citrate and bupivacaine hydrochloride mixtures in standard infusion solutions of 0.9% sodium chloride and 5% glucose. AFTER OPTIMISATION, THE HPLC METHOD PARAMETERS WERE AS FOLLOWS: LiChrospher 100 CN, 250×4 mm (10 µm) column; mobile phase: mixture of acetonitrile and phosphate buffer at pH 2.8 (3:7, V/V) with addition of 0.08 g/l potassium chloride; flow rate: 1.5 ml/min; column temperature: 30°C; spectrophotometric detection at 210 nm. Development of the method involved checking the impact of acetonitrile and KCl concentrations in the mobile phase and choosing the internal standard. Method validation included determining the specificity of the method, its accuracy, linearity, precision, repeatability, limits of detection and quantification. The retention times of bupivacaine hydrochloride, fentanyl citrate and procaine hydrochloride, used as an internal standard, were approximately 10 min, 15 min and 5 min, respectively. Method validation confirmed its selectivity, accuracy and precision. The average values of the variation and accuracy coefficients were 0.70% and 99.02% for bupivacaine hydrochloride, and 1.76% and 104.53% for fentanyl citrate. The intermediate precision values were 1.25% for bupivacaine hydrochloride and 1.52% for fentanyl citrate.

UI MeSH Term Description Entries

Related Publications

Mikołaj Piekarski, and Anna Jelin'ska, and Kamil Szymczak
April 1993, American journal of hospital pharmacy,
Mikołaj Piekarski, and Anna Jelin'ska, and Kamil Szymczak
September 1990, American journal of hospital pharmacy,
Mikołaj Piekarski, and Anna Jelin'ska, and Kamil Szymczak
April 1992, British journal of anaesthesia,
Mikołaj Piekarski, and Anna Jelin'ska, and Kamil Szymczak
January 1998, International journal of pharmaceutical compounding,
Mikołaj Piekarski, and Anna Jelin'ska, and Kamil Szymczak
August 1999, Journal of pharmaceutical and biomedical analysis,
Mikołaj Piekarski, and Anna Jelin'ska, and Kamil Szymczak
May 1995, Pharmacy world & science : PWS,
Mikołaj Piekarski, and Anna Jelin'ska, and Kamil Szymczak
January 2010, Journal of AOAC International,
Mikołaj Piekarski, and Anna Jelin'ska, and Kamil Szymczak
July 1998, Journal of pain and symptom management,
Mikołaj Piekarski, and Anna Jelin'ska, and Kamil Szymczak
January 2016, Acta pharmaceutica Sinica. B,
Copied contents to your clipboard!